GenAI in Action: TCG Lifesciences Envisions to Drive Productivity of R&D Team Through GenAI-Led Knowledge Management
This IDC Perspective examines the adoption level of generative AI (GenAI) technologies in TCG Lifesciences Pvt. Limited (TCGLS). The document's objective is to provide enterprises with practical insights and guidance relating to GenAI solutions adoption and ways of leveraging it to deliver to a wide range of use cases across the enterprise."Leveraging AI for productivity gains is only the tip of the iceberg. Enterprises' ability to build differentiation in the market and create new business models using AI will be a game-changer. Leaders must adopt different approaches to maximize AI potential in their organizations, specifically GenAI. AI and GenAI will disrupt every industry in the near future through a multitude of use cases, ranging from intelligent knowledge search to innovative customer engagement," says Deepika Giri, associate VP, Data and AI, IDC Asia/Pacific.
Please Note: Extended description available upon request.
- Executive Snapshot
- Situation Overview
- Company Overview
- Digital Transformation and Future of Intelligence Strategy
- Usage of Traditional AI — Application in Chemical Synthesis to Increase Yield Percentage, Drive Scientist Productivity, and Save Cost
- Generative AI Journey at TCGLS
- Generative AI Decision Making — Build versus Buy
- Generative AI Risks and Concerns
- Advice for the Technology Buyer
- Learn More
- Related Research
- Synopsis
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook